Skip to menu Skip to content Skip to footer

Phase1 randomized placebo-controlled double blind dose-escalation study of safety tolerability pharmacokinetics pharmacodynamics & immunogenicity of intravenous dose PF-04360365 (RN119) - altzheimers (2007-2009)

Experts

Professor Gerard Byrne

Mayne Professor of Psychiatry
Medical School
Faculty of Health, Medicine and Behavioural Sciences
Gerard Byrne
Gerard Byrne